Imagine what could happen if a religious zealot possessing wealth, power, and bio-technical genius, came into possession of a thorn from the Crown of Thorns placed upon Jesus’ head at the time of His Crucifixion. Richard Francis Craig had such a thorn and recovered Jesus’s DNA from its fossilized remains. He then joined forces with two progressive members of the Church, Cardinal Giovanni and Bishop Bellarmine, and a biotech wunderkind, Kristjan Evans. They have the technology to read His genetic code, a gift from God given through the Immaculate Conception of Mary and the Virgin Birth of Jesus. Dare they go further? Do they have the courage to use His genetic information to recreate the essence of Jesus, His clone, resurrecting Him to usher in the Second Coming and End of Times, the Final Judgement? Richard Craig made his fortune using his technological genius to found the biopharmaceutical company GenFlux. He was brought up in a strict Christian family by a stern father, a minister in the Redemption Church, and an architect of the God Box. While in the God Box Richard had his vision of Revelation and the Second Coming. The world is in chaos approaching the years of Tribulation and Richard believed God’s desire was for Man to save himself. Did not Mankind discover medical breakthroughs that prevented misery and death? Did Richard not develop medical breakthroughs that cured illness and alleviated suffering? Did Man not harness the power of the atom and the power of DNA, the life force? Richard often felt he was chosen to be a Prophet of the Lord. He knew Mankind possessed the power to control the life force itself, DNA, and thus the life essence of any organism whose DNA sequence Man could acquire. Assisted by Cardinal Giovanni, Bishop Bellarmine, and fellow technological genius Kristjan Evans, Richard Craig formulated his plan to clone Jesus and hasten the Second Coming of Christ, the Final Judgment, and the End of Times.

© 2024 Auric Thunder Books and Recordings (Lydbok): 9798875182501

Utgivelsesdato

Lydbok: 5. oktober 2024